A Prospective Collection of Peripheral Blood from Adults for CYFRA 21-1, SCC and NSE Assay Reference Range Determination
Global Lyme Alliance Bio & Data Repositories
Addario Lung Cancer Medical Institute Bio & Data Repositories
Epidemiology of Young Lung Cancer
An Exploratory Observational & Biospecimen Collection Study from Lyme Disease Patients Treated With the Jemsek Protocol®
A Prospective Longitudinal Collection of Peripheral Blood to Support the Validation of Biomarkers as an Aid in Monitoring Disease in Patients with all Stages of Lung Cancer
A Prospective Biospecimen Collection Study from Patients with EGFR mutant Tumors
A Blood Collection from Patients Presenting with Suspected New Onset of Exacerbated Heart Failure
SPACWALK: Study of Plasma Next Generation Sequencing for Remote Assessment, Characterization, Evaluation of Patients With ALK Drug Resistance
Prospective Collection of Anti-Mullerian Hormone (AMH) for Assessing Ovarian Reserve Prior to Infertility Therapy
Blood Collection from Patients to Evaluate for Anti-Mullerian Hormone (AMH) Measurement Differences Using Various Specimen Collection Tubes
LIBERTI: Role of Circulating Tumor DNA (ctDNA) from Liquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation
Blood Collection from Patients to Evaluate for Whole Parathyroid Hormone Measurement Differences Using Various Specimen Collection Tubes
Evaluation of Liquid Biopsies in Localized and Advanced Lung Cancer Patients
A Prospective Biospecimen Collection Study from Patients with ROS1-Fusion Positive Tumors
Evaluation of a Collection of Archival Tumor Tissue Specimens from Patients Diagnosed with Infantile Fibrosarcoma to Support the Analytical Validation of Diagnostic Assays
Blood Collection from Patients to Evaluate for TSH, Testosterone and βHCG Measurement Differences Using Various Specimen Collection Tubes
Phase II Study of Pembrolizumab and Epacadostat for Small Cell Lung Cancer after Prior Platinum-Based Therapy
A Prospective Longitudinal Study of CA 19-9 as an Aid in Monitoring Disease in Patients with Pancreatic Cancer
A Prospective Longitudinal Study of CA 15-3 as an Aid in Monitoring Recurrence of Progressive Disease in Patients With Breast Cancer
Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network
INHERIT EGFR - Investigating Hereditary Risk from T790M: A multi-centered study to identify and characterize individuals carrying germline EGFR mutations
Genomics of Young Lung Cancer (GoYLC) Study
A Blood Collection from Patients Prescribed a Laboratory Test to Screen for Syphilis
A Prospective Collection of Peripheral Blood Specimens to Study Fertility in Healthy, Premenopausal Women
A Blood Collection from Patients Presenting in the Emergency Department and Prescribed a Brain Natriuretic Peptide Laboratory Test
A randomized, multi-center, double blind and placebo-controlled study of loratadine as a synergistic agent to minocycline therapy for the treatment of patients with Acute Lyme Disease and Post-Treatment Lyme Disease Syndrome (PTLDS)
A Prospective Collection of Peripheral Blood and Urine Specimens to Study C-peptide and Glucose in Healthy Individuals
A Prospective Collection of Peripheral Blood Specimens to Study Vitamin D in Healthy Children
A Prospective Collection of Peripheral Blood Specimens to Study Vitamin D in Healthy Individuals
Clinical Specimen Collection Protocol: Oncology Study
Multiple Myeloma Research Consortium Biobank
MMRC: Diagnostic evaluation of t(4;14) in multiple myeloma and evidence for clonal evolution
Phase II: Low dose docetaxel, estramustine and thalidomide followed by maintenance thalidomide for the treatment of hormone refractory prostate cancer (HRPC).
Radiation Therapy in Treating Patients With Stage II of Stage III Prostate Cancer
Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes
Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin’s Lymphoma Who Have Previously Failed Rituxan Treatments
High-dose Interleukin-2 for the Treatment of Metastatic Renal Cell Carcinoma
High-dose Interleukin-2 for the Treatment of Metastatic Melanoma